Tinabinol
 | |
| Systematic (IUPAC) name | |
|---|---|
| 5,5-dimethyl-8-(3-methyl-2-octanyl)-1,2,3,5-tetrahydrothiopyrano[2,3-c]chromen-10-ol | |
| Clinical data | |
| Identifiers | |
| 50708-95-7 | |
| None | |
| PubChem | CID 65443 |
| ChemSpider | 58905 |
| Chemical data | |
| Formula | C23H34O2S |
| 374.580 g/mol | |
|
SMILES
| |
| |
Tinabinol (INN; SP-119) is a synthetic cannabinoid drug and analogue of dronabinol which was patented as an antihypertensive but was never marketed.[1][2]
See also
- Dronabinol
- Nabitan
References
- ↑ David T. Brown (19 November 1998). Cannabis: The Genus Cannabis. CRC Press. p. 80. ISBN 978-90-5702-291-3. Retrieved 27 April 2012.
- ↑ Martin Negwer (1994). Organic-chemical drugs and their synonyms: an international survey. Indices. Akad.-Verl. p. 2242. ISBN 978-3-05-501629-5. Retrieved 27 April 2012.
| ||||||||||||||||||||||||||||||||||||||||||||